NCT01582932 2019-01-22
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
Mayne Pharma International Pty Ltd
Phase 1 Completed
Mayne Pharma International Pty Ltd
Stanford University
Dong-A University
Washington University School of Medicine